Discounted Cash Flow
Surgery Partners, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2015 | $959.9m | $1.4m | $51.0m | 0.1% | $0.04 |
| 2016 | $1.1b (19.3%) | $9.5m (561.5%) | $86.1m (68.7%) | 0.8% (454.4%) | $0.20 (400.0%) |
| 2018 | $1.8b (54.7%) | $-205.7m (-2276.1%) | $104.8m (21.7%) | -11.6% (-1507.1%) | $-4.96 (-2580.0%) |
| 2019 | $1.8b (3.4%) | $-74.8m (63.6%) | $55.9m (-46.7%) | -4.1% (64.8%) | $-2.29 (53.8%) |
| 2020 | $1.9b (1.6%) | $-116.1m (-55.2%) | $204.0m (264.9%) | -6.2% (-52.8%) | $-3.19 (-39.3%) |
| 2021 | $2.2b (19.6%) | $-70.9m (38.9%) | $29.5m (-85.5%) | -3.2% (48.9%) | $-1.12 (64.9%) |
| 2022 | $2.5b (14.1%) | $-54.6m (23.0%) | $78.2m (165.1%) | -2.2% (32.5%) | $-0.59 (47.3%) |
| 2023 | $2.7b (8.0%) | $-11.9m (78.2%) | $205.0m (162.1%) | -0.4% (79.8%) | $-0.09 (84.7%) |
| 2024 | $3.1b (13.5%) | $-168.1m (-1312.6%) | $209.7m (2.3%) | -5.4% (-1144.3%) | $-1.33 (-1377.8%) |
| 2025 | $3.3b (6.2%) | $-77.9m (53.7%) | $195.6m (-6.7%) | -2.4% (56.4%) | $-0.61 (54.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.